NuSkin Enterprises (NUS)
NYSE Market Open
Nu Skin Enterprises, Inc. is a global beauty and wellness company that develops, markets, and sells personal care products, nutritional supplements, and related consumer technologies. The company is best known for the Nu Skin brand, which spans skin care, beauty devices, and anti-aging products, and Pharmanex, its wellness and nutrition line. Its products are distributed internationally through a direct selling model supported by independent sales leaders, social commerce tools, and local market operations.
Nu Skin reports its business across a broad geographic footprint that includes the Americas, Mainland China, Southeast Asia/Pacific, Japan, South Korea, Europe & Africa, and Hong Kong/Taiwan. This structure reflects the company’s reliance on local consumer preferences, regulatory environments, and distributor networks in each region. The Americas segment is a particularly important contributor, and wellness products represent a major part of total revenue.
Beyond its core branded consumer business, Nu Skin operates Rhyz, a strategic investment and operating platform. Rhyz includes manufacturing and packaging assets that support product development and supply chain capabilities, as well as other investments intended to broaden the company’s commercial reach. This gives Nu Skin exposure not only to consumer-facing beauty and wellness categories, but also to parts of the production infrastructure behind them.
The company competes in markets shaped by health-conscious consumers, premium skin care demand, and the growth of digital selling. Its performance depends on product innovation, brand engagement, distributor productivity, and the ability to navigate changing rules for direct selling and consumer products across global markets.
Last updated
- Market Cap
- 256.35M
- P/E
- 4.7
- P/FCF
- 6.17
- P/S
- 0.18
- Enterprise Value
- 281.29M
- Sector
- Health Care
- Industry
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Address
- 75 WEST CENTER ST, PROVO, UT, 84601
Global Derma Roller Market Size To Worth USD 668.17 Million By 2033 | CAGR OF 8.22%
Nu Skin (NUS) Up 5.6% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates
Why Is Inter Parfums (IPAR) Down 4.1% Since Last Earnings Report?
Nu Skin (NUS) Down 7.2% Since Last Earnings Report: Can It Rebound?
Nu Skin (NUS) Q4 Earnings Top Estimates, Revenues Decline Y/Y
Nu Skin Enterprises (NUS) Surpasses Q4 Earnings and Revenue Estimates
Things to Consider Ahead of Nu Skin's (NUS) Q4 Earnings
Philip Morris (PM) Lags Q4 Earnings Estimates
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
Nu Skin (NUS) Down More Than 20% in 3 Months: Here's Why
Why Is Inter Parfums (IPAR) Up 2.8% Since Last Earnings Report?
Nu Skin (NUS) Up 1% Since Last Earnings Report: Can It Continue?
Nu Skin (NUS) Misses Q3 Earnings Estimates, Lowers Guidance
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
e.l.f. Beauty (ELF) Readies for Q2 Earnings: Is a Beat Likely?
Things to Note Ahead of Nu Skin's (NUS) Q3 Earnings
Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth
Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 256.35M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 281.29M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 4.7
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.32
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.18
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 2.13
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.2
- EPS
- 1.12
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 7.1%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 6.17
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 3.37
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 41.57M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 6.87%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 3.96%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.28
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.03
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.34
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.77
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 631.2K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 5.28
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 320.61M | 370.32M | 364.21M | 386.14M | 364.49M |
| Gross profit | 214.46M | 261.98M | 256.72M | 265.73M | 246.96M |
| Operating income | 4.03M | 23.24M | 21.64M | 30.78M | -9.9M |
| EBITDA | 18.21M | 36.16M | 33.73M | 43.83M | 29.42M |
| Net income | 1.84M | 14.49M | 17.08M | 21.12M | 107.52M |
| Basic EPS | 0.04 | 0.31 | 0.35 | 0.43 | 2.16 |
| Diluted EPS | 0.04 | 0.27 | 0.34 | 0.43 | 2.14 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 1.38B | 1.41B | 1.42B | 1.44B | 1.39B |
| Total liabilities | 582.71M | 600.07M | 624.61M | 655.94M | 637.44M |
| Total equity | 794.09M | 805.24M | 799.8M | 787.75M | 753.97M |
| Cash & equivalents | 198.65M | 238.63M | 251.79M | 264.16M | 203.77M |
| Current assets | 522.89M | 547.7M | 548.14M | 571.55M | 524.86M |
| Current liabilities | 257M | 263.73M | 254.44M | 283.91M | 260.3M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -3.92M | 16.62M | 27.48M | 35.8M | 389K |
| Investing cash flow | -14.29M | -9.76M | -9.92M | 8.79M | 181.54M |
| Financing cash flow | -20.4M | -18.5M | -26.88M | 9.27M | -166.3M |
| Change in cash | -39.98M | -13.16M | -12.37M | 60.39M | 16.89M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — Winett James M | View Filing | |
| edgar index | S-8 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — CAMPBELL DANIEL W | View Filing | |
| form 4 | Form 4 — CAMPBELL DANIEL W | View Filing | |
| form 4 | Form 4 — CAMPBELL DANIEL W | View Filing | |
| form 4 | Form 4 — Thomas Pisano R. | View Filing | |
| form 4 | Form 4 — Battle Emma S. | View Filing | |
| form 4 | Form 4 — WOODBURY EDWINA D | View Filing | |
| form 4 | Form 4 — WOODBURY EDWINA D | View Filing | |
| form 4 | Form 4 — Zorko Mark A | View Filing | |
| form 4 | Form 4 — Nathanson Laura | View Filing | |
| form 4 | Form 4 — Winett James M | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SD — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 144 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — Nathanson Laura | View Filing | |
| edgar index | 10-Q — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | DEFA14A — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | ARS — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 3 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 3 | Form 3 — Lantz Chelsea K | View Filing | |
| edgar index | SCHEDULE 13G/A — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — WOODBURY EDWINA D | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 8-K — NU SKIN ENTERPRISES, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — NAPIERSKI RYAN S | View Filing | |
| form 4 | Form 4 — Thomas James D | View Filing | |
| form 4 | Form 4 — Clark Chayce David | View Filing | |
| form 4 | Form 4 — Hatchett Steven Keith | View Filing | |
| form 4 | Form 4 — Keisel Justin S | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — NAPIERSKI RYAN S | View Filing | |
| form 4 | Form 4 — Thomas James D | View Filing | |
| form 4 | Form 4 — Clark Chayce David | View Filing | |
| form 4 | Form 4 — Hatchett Steven Keith | View Filing | |
| form 4 | Form 4 — Keisel Justin S | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| edgar index | 4 — NU SKIN ENTERPRISES, INC. | View Filing | |
| form 4 | Form 4 — NAPIERSKI RYAN S | View Filing | |
| form 4 | Form 4 — Thomas James D | View Filing | |
| form 4 | Form 4 — Clark Chayce David | View Filing |